Publications
Detailed Information
Reduction in the protein level of c-Jun and phosphorylation of Ser73-c-Jun in rat frontal cortex after repeated MK-801 treatment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Yong Min | - |
dc.contributor.author | Seo, Myoung Suk | - |
dc.contributor.author | Kim, Se Hyun | - |
dc.contributor.author | Jeon, Won Je | - |
dc.contributor.author | Kang, Ung Gu | - |
dc.contributor.author | Kim, Yong Sik | - |
dc.contributor.author | Juhnn, Yong-Sung | - |
dc.contributor.author | Kim, Yeni | - |
dc.date.accessioned | 2012-06-05T06:10:46Z | - |
dc.date.available | 2012-06-05T06:10:46Z | - |
dc.date.issued | 2009-05-15 | - |
dc.identifier.citation | PSYCHIATRY RESEARCH; Vol.167 01월 02일; 80-87 | ko_KR |
dc.identifier.issn | 0165-1781 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76856 | - |
dc.description.abstract | Repeated administration of NMDA antagonists can induce behavioral alterations that mimic symptoms of psychosis, as seen in schizophrenia. JNK, one of the MAPKs, and c-Jun, its downstream target molecule, play important roles in regulating apoptosis in neural cells, and have been suggested as being associated with the pathophysiology of psychosis and the mechanism of action of some antipsychotics. We investigated changes in the JNK-c-Jun pathway and other Jun family proteins in the rat frontal cortex after single and repeated administration of MK-801 to examine acute and chronic responses. Neither the protein level nor the phosphorylation of JNK changed after single or repeated doses of MK-801. However, after repeated treatments, but not a single treatment, with MK-801, a down-regulation occurred in the protein level and of Ser73 phosphorylation of c-Jun in the rat frontal cortex. Other members of the Jun family, JunB and JunD, were unchanged. Repeated exposure to MK-801 down-regulated the phosphorylation and protein level of c-Jun in the rat frontal cortex, which may be related to the long-term effects of chronic treatment with MK-801. (C) 2008 Elsevier Ireland Ltd. All rights reserved. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ELSEVIER IRELAND LTD | ko_KR |
dc.subject | JNK | ko_KR |
dc.subject | MAPK | ko_KR |
dc.subject | NMDA receptor antagonist | ko_KR |
dc.subject | Psychotomimetic agent | ko_KR |
dc.subject | Psychosis | ko_KR |
dc.title | Reduction in the protein level of c-Jun and phosphorylation of Ser73-c-Jun in rat frontal cortex after repeated MK-801 treatment | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 안용민 | - |
dc.contributor.AlternativeAuthor | 서명숙 | - |
dc.contributor.AlternativeAuthor | 김세현 | - |
dc.contributor.AlternativeAuthor | 전원제 | - |
dc.contributor.AlternativeAuthor | 김예니 | - |
dc.contributor.AlternativeAuthor | 강웅구 | - |
dc.contributor.AlternativeAuthor | 전용성 | - |
dc.contributor.AlternativeAuthor | 김용식 | - |
dc.identifier.doi | 10.1016/j.psychres.2007.12.013 | - |
dc.citation.journaltitle | PSYCHIATRY RESEARCH | - |
dc.description.citedreference | Seo MS, 2007, INT J NEUROPSYCHOPH, V10, P359, DOI 10.1017/S1461145706006869 | - |
dc.description.citedreference | Kang UG, 2006, PSYCHIAT RES, V145, P75, DOI 10.1016/j.psychres.2006.05.020 | - |
dc.description.citedreference | Ahn YM, 2006, INT J NEUROPSYCHOPH, V9, P451, DOI 10.1017/S1461145705005882 | - |
dc.description.citedreference | Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005 | - |
dc.description.citedreference | Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006 | - |
dc.description.citedreference | Ahn YM, 2005, INT J NEUROPSYCHOPH, V8, P607, DOI 10.1017/S1461145705005353 | - |
dc.description.citedreference | Thomas DM, 2005, BRAIN RES, V1050, P190, DOI 10.1016/j.brainres.2005.05.049 | - |
dc.description.citedreference | MOLINUEVO JL, 2005, AM J ALZHEIMERS DIS, V20, P77 | - |
dc.description.citedreference | Vaisinen J, 2004, CELL MOL NEUROBIOL, V24, P769 | - |
dc.description.citedreference | Carter K, 2004, NEUROPHARMACOLOGY, V47, P1135, DOI 10.1016/j.neuropharm.2004.08.018 | - |
dc.description.citedreference | Keilhoff G, 2004, BIOL PSYCHIAT, V56, P317, DOI 10.1016/j.biopsych.2004.06.010 | - |
dc.description.citedreference | Kyosseva SV, 2004, PROG NEURO-PSYCHOPH, V28, P997, DOI 10.1016/j.pnpbp.2004.05.017 | - |
dc.description.citedreference | Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101 | - |
dc.description.citedreference | Waetzig V, 2003, MOL CELL NEUROSCI, V24, P238, DOI 10.1016/S1044-7431(03)00126-X | - |
dc.description.citedreference | Todorova VK, 2003, NEUROPSYCHOPHARMACOL, V28, P1506, DOI 10.1038/sj.npp.1300211 | - |
dc.description.citedreference | Takahata R, 2003, NEUROPSYCHOPHARMACOL, V28, P1117, DOI 10.1038/sj.npp.1300127 | - |
dc.description.citedreference | Paulson L, 2003, J NEUROSCI RES, V71, P526, DOI 10.1002/jnr.10509 | - |
dc.description.citedreference | Kitayama T, 2003, J NEUROCHEM, V84, P767, DOI 10.1046/j.0022-3042.2003.01567.x | - |
dc.description.citedreference | Yang PB, 2002, BRAIN RES, V954, P151 | - |
dc.description.citedreference | Deng XL, 2002, MOL PHARMACOL, V62, P993 | - |
dc.description.citedreference | Kontkanen O, 2002, NEUROPSYCHOPHARMACOL, V27, P152 | - |
dc.description.citedreference | Ahn YM, 2002, PROG NEURO-PSYCHOPH, V26, P513 | - |
dc.description.citedreference | Kyosseva SV, 2001, NEUROPSYCHOPHARMACOL, V24, P267 | - |
dc.description.citedreference | Muller S, 2000, J BIOL CHEM, V275, P13321 | - |
dc.description.citedreference | Tomitaka M, 2000, BIOL PSYCHIAT, V47, P836 | - |
dc.description.citedreference | Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650 | - |
dc.description.citedreference | Andine P, 1999, J PHARMACOL EXP THER, V290, P1393 | - |
dc.description.citedreference | Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201 | - |
dc.description.citedreference | Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751 | - |
dc.description.citedreference | BRECHT S, 1999, BRAIN RES MOL BRAIN, V68, P101 | - |
dc.description.citedreference | Gao XM, 1998, SYNAPSE, V29, P14 | - |
dc.description.citedreference | Eilers A, 1998, J NEUROSCI, V18, P1713 | - |
dc.description.citedreference | Watson A, 1998, J NEUROSCI, V18, P751 | - |
dc.description.citedreference | Jentsch JD, 1997, NEUROPSYCHOPHARMACOL, V17, P92 | - |
dc.description.citedreference | Musti AM, 1997, SCIENCE, V275, P400 | - |
dc.description.citedreference | OLNEY JW, 1995, NEUROPSYCHOPHARMACOL, V13, P335 | - |
dc.description.citedreference | XIA ZG, 1995, SCIENCE, V270, P1326 | - |
dc.description.citedreference | CAREY RJ, 1995, PHARMACOL BIOCHEM BE, V51, P901 | - |
dc.description.citedreference | KYRIAKIS JM, 1994, NATURE, V369, P156 | - |
dc.description.citedreference | WEDZONY K, 1993, BRAIN RES, V625, P333 | - |
dc.description.citedreference | GASS P, 1993, NEUROSCIENCE, V53, P749 | - |
dc.description.citedreference | SHARP FR, 1991, ANN NEUROL, V30, P801 | - |
dc.description.citedreference | PULVERER BJ, 1991, NATURE, V353, P670 | - |
dc.description.citedreference | HERTZMAN M, 1990, AM J PSYCHIAT, V147, P255 | - |
dc.description.tc | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.